APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

24 hedge funds and large institutions have $4.71M invested in Aptose Biosciences, Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.92K
2
+$835
3
+$464
4
CSC
Caldwell Sutter Capital
California
+$427
5
TRCT
Tower Research Capital (TRC)
New York
+$135

Top Sellers

1
-$925K
2
-$862K
3
-$205K
4
VC
Voss Capital
Texas
-$102K
5
FAM
Formidable Asset Management
Ohio
-$58K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2